R&D Tax Credits: Practical Guides for Finance Directors

Plain-English guides covering eligibility, qualifying expenditure, HMRC process, and the April 2024 scheme changes. Written for the FD or CFO who needs answers, not jargon.

Quick answer: The Uplift Tax blog publishes plain-English guides on UK R&D tax credits for finance directors and CFOs, covering eligibility, qualifying expenditure, HMRC process, the April 2024 merged scheme, ERIS for loss-making companies, and sector-specific worked examples. No jargon, no sales pitch.

Not sure if your company qualifies?

We review your company profile and send you a free written assessment from a specialist. No cost. No obligation.

Request Your Free Assessment

Frequently asked questions

The SME (Small and Medium Enterprise) scheme and the Research and Development Expenditure Credit (RDEC) were two separate R&D tax credit schemes in the UK. From April 2024, a new merged scheme replaced both for most companies, with an above-the-line credit rate of 20%. A separate enhanced SME scheme remains for R&D-intensive loss-making SMEs.

April 2024 brought significant changes to UK R&D tax credits. HMRC introduced a merged RDEC-style scheme replacing the previous SME and RDEC schemes for most companies. The merged scheme provides a 20% above-the-line credit. Qualifying expenditure categories also expanded to include some overseas costs and pure mathematics.

The Additional Information Form (AIF) is a mandatory online submission that HMRC requires before processing any R&D tax credit claim. It must be submitted via HMRC’s online service before or at the same time as the Company Tax Return. It includes details of the qualifying R&D projects and expenditure categories.

Enhanced R&D Intensive Support (ERIS) is available to loss-making SMEs whose qualifying R&D expenditure is at least 30% of their total expenditure. Qualifying companies receive an enhanced 186% deduction and a 14.5% payable credit rate on the surrenderable loss, producing a net cash benefit of approximately 27p for every £1 of qualifying spend.

The merged scheme gives all qualifying companies a 20% above-the-line credit, taxable as trading income, producing a net benefit of approximately 15p per £1 of qualifying spend after corporation tax for a profitable company. ERIS is a separate, more generous route for loss-making SMEs that meet the 30% R&D-intensity threshold, and is not an add-on to the merged scheme; a company claims under one or the other for a given period.

Yes. HMRC requires a new Additional Information Form for every accounting period in which a claim is made, even where the company claimed in the prior period and the underlying projects are similar. Each AIF must reflect that period's own projects and expenditure.